Hotline: +86-18022463983    020-85206863

Global Endocrinology and Metabolism Market Research Report 2026

Published Date: 2026-03-30   |   Pages: 116   |   Tables: 117   |  Medical Care

The global Endocrinology and Metabolism market was valued at US$ 105550 million in 2025 and is anticipated to reach US$ 219550 million by 2032, at a CAGR of 11.2% from 2026 to 2032.
Endocrinology is the internal medicine subspecialty dedicated to the diagnosis and care of diseases and conditions related to the endocrine glands, hormones, and metabolism, the body’s physical and chemical processes to use energy or convert it for use. These diseases and conditions include type 1 and type 2 diabetes; obesity; conditions of the pituitary, thyroid, parathyroid, and adrenal glands; and metabolic disorders.
The rising frequency of endocrine problems, including diabetes, thyroid disorders, and hormonal imbalances, is another major factor driving the endocrinology and metabolism market. Sedentary lifestyles, bad eating habits, rising obesity rates, and an aging population all contribute to the growing global burden of endocrine illnesses. As the frequency and prevalence of these problems rise, so does the demand for diagnostic tests, medicines, and treatment procedures that address endocrine and metabolic abnormalities. This spike in demand opens up attractive prospects for market players to offer innovative products and services to meet the growing healthcare needs of people with endocrine diseases.
This report delivers a comprehensive overview of the global Endocrinology and Metabolism market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Endocrinology and Metabolism. The Endocrinology and Metabolism market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Endocrinology and Metabolism market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Endocrinology and Metabolism manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Abbott Laboratories
Acerus Pharmaceuticals Corp.
Ascendis Pharma AS
Bayer AG
Beta Cell NV
Biocon Ltd.
Eli Lilly and Co.
Endo International Plc
Hoffmann La Roche Ltd.
GlaxoSmithKline Plc
Hanmi Pharm Co. Ltd.
Ipsen Pharma
Segment by Type
Diabetes Drugs
HGH
Thyroid Hormone Disorders
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Endocrinology and Metabolism companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrinology and Metabolism Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Diabetes Drugs
1.2.3 HGH
1.2.4 Thyroid Hormone Disorders
1.2.5 Others
1.3 Market by Application
1.3.1 Global Endocrinology and Metabolism Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocrinology and Metabolism Market Perspective (2021–2032)
2.2 Global Endocrinology and Metabolism Growth Trends by Region
2.2.1 Global Endocrinology and Metabolism Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Endocrinology and Metabolism Historic Market Size by Region (2021–2026)
2.2.3 Endocrinology and Metabolism Forecasted Market Size by Region (2027–2032)
2.3 Endocrinology and Metabolism Market Dynamics
2.3.1 Endocrinology and Metabolism Industry Trends
2.3.2 Endocrinology and Metabolism Market Drivers
2.3.3 Endocrinology and Metabolism Market Challenges
2.3.4 Endocrinology and Metabolism Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrinology and Metabolism Players by Revenue
3.1.1 Global Top Endocrinology and Metabolism Players by Revenue (2021–2026)
3.1.2 Global Endocrinology and Metabolism Revenue Market Share by Players (2021–2026)
3.2 Global Top Endocrinology and Metabolism Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Endocrinology and Metabolism Revenue
3.4 Global Endocrinology and Metabolism Market Concentration Ratio
3.4.1 Global Endocrinology and Metabolism Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrinology and Metabolism Revenue in 2025
3.5 Global Key Players of Endocrinology and Metabolism Head Offices and Areas Served
3.6 Global Key Players of Endocrinology and Metabolism, Products and Applications
3.7 Global Key Players of Endocrinology and Metabolism, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Endocrinology and Metabolism Breakdown Data by Type
4.1 Global Endocrinology and Metabolism Historic Market Size by Type (2021–2026)
4.2 Global Endocrinology and Metabolism Forecasted Market Size by Type (2027–2032)
5 Endocrinology and Metabolism Breakdown Data by Application
5.1 Global Endocrinology and Metabolism Historic Market Size by Application (2021–2026)
5.2 Global Endocrinology and Metabolism Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Endocrinology and Metabolism Market Size (2021–2032)
6.2 North America Endocrinology and Metabolism Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Endocrinology and Metabolism Market Size by Country (2021–2026)
6.4 North America Endocrinology and Metabolism Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endocrinology and Metabolism Market Size (2021–2032)
7.2 Europe Endocrinology and Metabolism Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Endocrinology and Metabolism Market Size by Country (2021–2026)
7.4 Europe Endocrinology and Metabolism Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Endocrinology and Metabolism Market Size (2021–2032)
8.2 Asia-Pacific Endocrinology and Metabolism Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Endocrinology and Metabolism Market Size by Region (2021–2026)
8.4 Asia-Pacific Endocrinology and Metabolism Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Endocrinology and Metabolism Market Size (2021–2032)
9.2 Latin America Endocrinology and Metabolism Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Endocrinology and Metabolism Market Size by Country (2021–2026)
9.4 Latin America Endocrinology and Metabolism Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrinology and Metabolism Market Size (2021–2032)
10.2 Middle East & Africa Endocrinology and Metabolism Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Endocrinology and Metabolism Market Size by Country (2021–2026)
10.4 Middle East & Africa Endocrinology and Metabolism Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Endocrinology and Metabolism Introduction
11.1.4 Abbott Laboratories Revenue in Endocrinology and Metabolism Business (2021–2026)
11.1.5 Abbott Laboratories Recent Development
11.2 Acerus Pharmaceuticals Corp.
11.2.1 Acerus Pharmaceuticals Corp. Company Details
11.2.2 Acerus Pharmaceuticals Corp. Business Overview
11.2.3 Acerus Pharmaceuticals Corp. Endocrinology and Metabolism Introduction
11.2.4 Acerus Pharmaceuticals Corp. Revenue in Endocrinology and Metabolism Business (2021–2026)
11.2.5 Acerus Pharmaceuticals Corp. Recent Development
11.3 Ascendis Pharma AS
11.3.1 Ascendis Pharma AS Company Details
11.3.2 Ascendis Pharma AS Business Overview
11.3.3 Ascendis Pharma AS Endocrinology and Metabolism Introduction
11.3.4 Ascendis Pharma AS Revenue in Endocrinology and Metabolism Business (2021–2026)
11.3.5 Ascendis Pharma AS Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Endocrinology and Metabolism Introduction
11.4.4 Bayer AG Revenue in Endocrinology and Metabolism Business (2021–2026)
11.4.5 Bayer AG Recent Development
11.5 Beta Cell NV
11.5.1 Beta Cell NV Company Details
11.5.2 Beta Cell NV Business Overview
11.5.3 Beta Cell NV Endocrinology and Metabolism Introduction
11.5.4 Beta Cell NV Revenue in Endocrinology and Metabolism Business (2021–2026)
11.5.5 Beta Cell NV Recent Development
11.6 Biocon Ltd.
11.6.1 Biocon Ltd. Company Details
11.6.2 Biocon Ltd. Business Overview
11.6.3 Biocon Ltd. Endocrinology and Metabolism Introduction
11.6.4 Biocon Ltd. Revenue in Endocrinology and Metabolism Business (2021–2026)
11.6.5 Biocon Ltd. Recent Development
11.7 Eli Lilly and Co.
11.7.1 Eli Lilly and Co. Company Details
11.7.2 Eli Lilly and Co. Business Overview
11.7.3 Eli Lilly and Co. Endocrinology and Metabolism Introduction
11.7.4 Eli Lilly and Co. Revenue in Endocrinology and Metabolism Business (2021–2026)
11.7.5 Eli Lilly and Co. Recent Development
11.8 Endo International Plc
11.8.1 Endo International Plc Company Details
11.8.2 Endo International Plc Business Overview
11.8.3 Endo International Plc Endocrinology and Metabolism Introduction
11.8.4 Endo International Plc Revenue in Endocrinology and Metabolism Business (2021–2026)
11.8.5 Endo International Plc Recent Development
11.9 Hoffmann La Roche Ltd.
11.9.1 Hoffmann La Roche Ltd. Company Details
11.9.2 Hoffmann La Roche Ltd. Business Overview
11.9.3 Hoffmann La Roche Ltd. Endocrinology and Metabolism Introduction
11.9.4 Hoffmann La Roche Ltd. Revenue in Endocrinology and Metabolism Business (2021–2026)
11.9.5 Hoffmann La Roche Ltd. Recent Development
11.10 GlaxoSmithKline Plc
11.10.1 GlaxoSmithKline Plc Company Details
11.10.2 GlaxoSmithKline Plc Business Overview
11.10.3 GlaxoSmithKline Plc Endocrinology and Metabolism Introduction
11.10.4 GlaxoSmithKline Plc Revenue in Endocrinology and Metabolism Business (2021–2026)
11.10.5 GlaxoSmithKline Plc Recent Development
11.11 Hanmi Pharm Co. Ltd.
11.11.1 Hanmi Pharm Co. Ltd. Company Details
11.11.2 Hanmi Pharm Co. Ltd. Business Overview
11.11.3 Hanmi Pharm Co. Ltd. Endocrinology and Metabolism Introduction
11.11.4 Hanmi Pharm Co. Ltd. Revenue in Endocrinology and Metabolism Business (2021–2026)
11.11.5 Hanmi Pharm Co. Ltd. Recent Development
11.12 Ipsen Pharma
11.12.1 Ipsen Pharma Company Details
11.12.2 Ipsen Pharma Business Overview
11.12.3 Ipsen Pharma Endocrinology and Metabolism Introduction
11.12.4 Ipsen Pharma Revenue in Endocrinology and Metabolism Business (2021–2026)
11.12.5 Ipsen Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Endocrinology and Metabolism Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Diabetes Drugs
Table 3. Key Players of HGH
Table 4. Key Players of Thyroid Hormone Disorders
Table 5. Key Players of Others
Table 6. Global Endocrinology and Metabolism Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Endocrinology and Metabolism Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Endocrinology and Metabolism Market Size by Region (US$ Million), 2021–2026
Table 9. Global Endocrinology and Metabolism Market Share by Region (2021–2026)
Table 10. Global Endocrinology and Metabolism Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Endocrinology and Metabolism Market Share by Region (2027–2032)
Table 12. Endocrinology and Metabolism Market Trends
Table 13. Endocrinology and Metabolism Market Drivers
Table 14. Endocrinology and Metabolism Market Challenges
Table 15. Endocrinology and Metabolism Market Restraints
Table 16. Global Endocrinology and Metabolism Revenue by Players (US$ Million), 2021–2026
Table 17. Global Endocrinology and Metabolism Market Share by Players (2021–2026)
Table 18. Global Top Endocrinology and Metabolism Players by Tier (Tier 1, Tier 2, and Tier 3), based on Endocrinology and Metabolism Revenue, 2025
Table 19. Ranking of Global Top Endocrinology and Metabolism Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Endocrinology and Metabolism Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Endocrinology and Metabolism, Headquarters and Area Served
Table 22. Global Key Players of Endocrinology and Metabolism, Products and Applications
Table 23. Global Key Players of Endocrinology and Metabolism, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Endocrinology and Metabolism Market Size by Type (US$ Million), 2021–2026
Table 26. Global Endocrinology and Metabolism Revenue Market Share by Type (2021–2026)
Table 27. Global Endocrinology and Metabolism Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Endocrinology and Metabolism Revenue Market Share by Type (2027–2032)
Table 29. Global Endocrinology and Metabolism Market Size by Application (US$ Million), 2021–2026
Table 30. Global Endocrinology and Metabolism Revenue Market Share by Application (2021–2026)
Table 31. Global Endocrinology and Metabolism Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Endocrinology and Metabolism Revenue Market Share by Application (2027–2032)
Table 33. North America Endocrinology and Metabolism Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Endocrinology and Metabolism Market Size by Country (US$ Million), 2021–2026
Table 35. North America Endocrinology and Metabolism Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Endocrinology and Metabolism Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Endocrinology and Metabolism Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Endocrinology and Metabolism Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Endocrinology and Metabolism Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Endocrinology and Metabolism Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Endocrinology and Metabolism Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Endocrinology and Metabolism Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Endocrinology and Metabolism Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Endocrinology and Metabolism Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Endocrinology and Metabolism Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Endocrinology and Metabolism Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Endocrinology and Metabolism Market Size by Country (US$ Million), 2027–2032
Table 48. Abbott Laboratories Company Details
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Endocrinology and Metabolism Product
Table 51. Abbott Laboratories Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
Table 52. Abbott Laboratories Recent Development
Table 53. Acerus Pharmaceuticals Corp. Company Details
Table 54. Acerus Pharmaceuticals Corp. Business Overview
Table 55. Acerus Pharmaceuticals Corp. Endocrinology and Metabolism Product
Table 56. Acerus Pharmaceuticals Corp. Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
Table 57. Acerus Pharmaceuticals Corp. Recent Development
Table 58. Ascendis Pharma AS Company Details
Table 59. Ascendis Pharma AS Business Overview
Table 60. Ascendis Pharma AS Endocrinology and Metabolism Product
Table 61. Ascendis Pharma AS Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
Table 62. Ascendis Pharma AS Recent Development
Table 63. Bayer AG Company Details
Table 64. Bayer AG Business Overview
Table 65. Bayer AG Endocrinology and Metabolism Product
Table 66. Bayer AG Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
Table 67. Bayer AG Recent Development
Table 68. Beta Cell NV Company Details
Table 69. Beta Cell NV Business Overview
Table 70. Beta Cell NV Endocrinology and Metabolism Product
Table 71. Beta Cell NV Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
Table 72. Beta Cell NV Recent Development
Table 73. Biocon Ltd. Company Details
Table 74. Biocon Ltd. Business Overview
Table 75. Biocon Ltd. Endocrinology and Metabolism Product
Table 76. Biocon Ltd. Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
Table 77. Biocon Ltd. Recent Development
Table 78. Eli Lilly and Co. Company Details
Table 79. Eli Lilly and Co. Business Overview
Table 80. Eli Lilly and Co. Endocrinology and Metabolism Product
Table 81. Eli Lilly and Co. Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
Table 82. Eli Lilly and Co. Recent Development
Table 83. Endo International Plc Company Details
Table 84. Endo International Plc Business Overview
Table 85. Endo International Plc Endocrinology and Metabolism Product
Table 86. Endo International Plc Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
Table 87. Endo International Plc Recent Development
Table 88. Hoffmann La Roche Ltd. Company Details
Table 89. Hoffmann La Roche Ltd. Business Overview
Table 90. Hoffmann La Roche Ltd. Endocrinology and Metabolism Product
Table 91. Hoffmann La Roche Ltd. Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
Table 92. Hoffmann La Roche Ltd. Recent Development
Table 93. GlaxoSmithKline Plc Company Details
Table 94. GlaxoSmithKline Plc Business Overview
Table 95. GlaxoSmithKline Plc Endocrinology and Metabolism Product
Table 96. GlaxoSmithKline Plc Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
Table 97. GlaxoSmithKline Plc Recent Development
Table 98. Hanmi Pharm Co. Ltd. Company Details
Table 99. Hanmi Pharm Co. Ltd. Business Overview
Table 100. Hanmi Pharm Co. Ltd. Endocrinology and Metabolism Product
Table 101. Hanmi Pharm Co. Ltd. Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
Table 102. Hanmi Pharm Co. Ltd. Recent Development
Table 103. Ipsen Pharma Company Details
Table 104. Ipsen Pharma Business Overview
Table 105. Ipsen Pharma Endocrinology and Metabolism Product
Table 106. Ipsen Pharma Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
Table 107. Ipsen Pharma Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report


List of Figures
Figure 1. Endocrinology and Metabolism Picture
Figure 2. Global Endocrinology and Metabolism Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Endocrinology and Metabolism Market Share by Type: 2025 vs 2032
Figure 4. Diabetes Drugs Features
Figure 5. HGH Features
Figure 6. Thyroid Hormone Disorders Features
Figure 7. Others Features
Figure 8. Global Endocrinology and Metabolism Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Endocrinology and Metabolism Market Share by Application: 2025 vs 2032
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Endocrinology and Metabolism Report Years Considered
Figure 14. Global Endocrinology and Metabolism Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Endocrinology and Metabolism Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Endocrinology and Metabolism Market Share by Region: 2025 vs 2032
Figure 17. Global Endocrinology and Metabolism Market Share by Players in 2025
Figure 18. Global Endocrinology and Metabolism Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Endocrinology and Metabolism Revenue in 2025
Figure 20. North America Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Endocrinology and Metabolism Market Share by Country (2021–2032)
Figure 22. United States Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Endocrinology and Metabolism Market Share by Country (2021–2032)
Figure 26. Germany Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Endocrinology and Metabolism Market Share by Region (2021–2032)
Figure 34. China Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Endocrinology and Metabolism Market Share by Country (2021–2032)
Figure 42. Mexico Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Endocrinology and Metabolism Market Share by Country (2021–2032)
Figure 46. Israel Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Abbott Laboratories Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
Figure 50. Acerus Pharmaceuticals Corp. Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
Figure 51. Ascendis Pharma AS Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
Figure 52. Bayer AG Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
Figure 53. Beta Cell NV Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
Figure 54. Biocon Ltd. Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
Figure 55. Eli Lilly and Co. Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
Figure 56. Endo International Plc Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
Figure 57. Hoffmann La Roche Ltd. Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
Figure 58. GlaxoSmithKline Plc Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
Figure 59. Hanmi Pharm Co. Ltd. Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
Figure 60. Ipsen Pharma Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Our Clients